Jul 21st 2020

Amend Surgical To Develop Wound-Closure Method Alternative Using Tough Gel Technology

Learn more about Amend Surgical's plans to develop an alternative to current wound-closure methods using Tough Gel Technology.

May 24th 2017

Florida Institute Funds Alachua-based Amend Surgical

The Florida Institute for the Commercialization of Public Research (the Florida Institute) announced today that it has finalized a funding agreement with Amend Surgical ...

Apr 06th 2017

Amend Surgical Signs Agreement With UFRF for Biomimetic Bone

Amend Surgical, Inc. (Amend), a medical device company focused on enhancing the regenerative capacity of bone replacement products, announced today an exclusive agreement with The University of Florida Research Foundation (UFRF) to license patents for the development of Biomimetic Bone, a novel artificial bone substitute.

Mar 02nd 2017

Amend Surgical Announces 510(K) Clearance for NanoFUSE® BA

Amend Surgical, Inc., announced today that they have received 510(K) clearance to market NanoFUSE® BA as a bone graft extender for spine and orthopedic applications.

Apr 15th 2016

Amend Surgical Granted Rights to NanoFUSE

Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, today announced that the Company has granted an exclusive worldwide license to its proprietary bone void filler product, NanoFUSE® DBM (demineralized bone matrix), to Alachua, FL-based Amend Surgical, Inc.